Product Information
PREGABALIN 50 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0471 per EA under NDC 69097067805. Its NADAC has been published 303 times since Nov 4, 2020.
FDA first approved this application on Jan 10, 2020.
Strength
50 mg/1
Manufacturer
Cipla USA Inc.NDC
69097067805
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212280FDA Approved
1/10/2020
On Market Since
1/10/2020
Price Statistics
The NADAC for PREGABALIN 50 MG CAPSULE has been published 303 times since Nov 4, 2020, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0471 per EA |
|---|---|
| All-time high | $0.1032 (Dec 16, 2020) |
| All-time low | $0.0398 (Nov 20, 2024) |
| 52-week high | $0.0509 |
| 52-week low | $0.0459 |
| Median price | $0.0647 |
| Average price | $0.0682 |
| Largest weekly change | -37.6% (Nov 20, 2024) |
| Weeks tracked | 303 |
| Tracking since | Nov 4, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PREGABALIN capsules, CV market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREGABALIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 50 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0471 per EA (NDC 69097067805), effective Aug 19, 2026.
How has the price of PREGABALIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 50 MG CAPSULE has declined 54.2%. It has been tracked across 303 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for PREGABALIN 50 MG CAPSULE?
Since Nov 4, 2020, the NADAC for PREGABALIN 50 MG CAPSULE has ranged from a low of $0.0398 (Nov 20, 2024) to a high of $0.1032 (Dec 16, 2020), with a median of $0.0647 per EA.
Are there cheaper alternatives to PREGABALIN 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of PREGABALIN 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PREGABALIN 50 MG CAPSULE?
PREGABALIN 50 MG CAPSULE (NDC 69097067805) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.